Genomic sequencing technologies, such as next-generation sequencing (NGS), have revolutionized cancer research and treatment. These technologies allow for comprehensive analysis of the cancer genome, identifying mutations, copy number alterations, and other genetic changes. This information can be used to guide treatment decisions, identify clinical trial opportunities, and monitor treatment response and resistance.
